Predict your next investment

HEALTHCARE | Drug Delivery
cellnovo.com

See what CB Insights has to offer

Competitors

14

Business Relationships

4

Service Providers

3

Cellnovo Competitors & Alternatives

14 Competitors

Cellnovo has 14 competitors. Cellnovo's competitors are Mirus Bio, Erydel, Medipacs, Iontera, Intercell and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

5/18/2021

Acq - Fin

$0.68M

Wisconsin

8/7/2020

Unattributed

$67.72M

Italy

10/30/2014

Series B - II

$5.49M

California

10/26/2013

Unattributed

$13.7M

Massachusetts

5/29/2013

Acq - P2P

Austria

4/26/2013

Orthocon

Acquired

$25.4M

New Jersey

4/8/2011

Medgenics

IPO

$9M

Pennsylvania

5/6/2009

Cambridge Eyenovations

Biz Plan Competition

Massachusetts

4/22/2008

Medi-Stream

Unattributed

$2.5M

Australia

10/1/2007

Acumen Medical

Acquired

California

Latest Funding

5/18/2021

8/7/2020

10/30/2014

10/26/2013

5/29/2013

4/26/2013

4/8/2011

5/6/2009

4/22/2008

10/1/2007

Companies

Orthocon

Medgenics

Cambridge Eyenovations

Medi-Stream

Acumen Medical

Investment Stage

Acq - Fin

Unattributed

Series B - II

Unattributed

Acq - P2P

Acquired

IPO

Biz Plan Competition

Unattributed

Acquired

Total Funding

$0.68M

$67.72M

$5.49M

$13.7M

$25.4M

$9M

$2.5M

Mosaic

Location

Wisconsin

Italy

California

Massachusetts

Austria

New Jersey

Pennsylvania

Massachusetts

Australia

California

Cellnovo Service Providers

3 Service Providers

Cellnovo has 3 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Canaccord Genuity Group

IPO

Investment Bank

Financial Advisor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Canaccord Genuity Group

Subscribe to see more

Subscribe to see more

Associated Rounds

IPO

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Subscribe to see more

Service Type

Financial Advisor

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Cellnovo Partners & Customers

4 Partners and customers

Cellnovo has 4 strategic partners and customers. Cellnovo recently partnered with ForaCare on December 12, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

12/3/2018

Partner

ForaCare

United States

Cellnovo and ForaCare Sign an Agreement to Connect ForaCare’s Glucose Monitoring Device to the Cellnovo Gen 3 System

Cellnovo , a medical technology company marketing the first connected diabetes management platform based on a locked-down AndroidTM smartphone communicating via Bluetooth with a small , discreet micro-pump , today announces an agreement with ForaCare to enable the automatic transfer of data from ForaCare 's FORA Diamond Mini ® blood glucose monitoring device to the Cellnovo .

1

9/13/2011

Partner

LifeScan

United States

Subscribe to see more

Subscribe to see more

10

Partner

Flex

Singapore

Subscribe to see more

Subscribe to see more

10

Partner

Home Diagnostics

United States

Subscribe to see more

Subscribe to see more

10

Date

12/3/2018

9/13/2011

Type

Partner

Partner

Partner

Partner

Business Partner

ForaCare

LifeScan

Flex

Home Diagnostics

Country

United States

United States

Singapore

United States

News Snippet

Cellnovo and ForaCare Sign an Agreement to Connect ForaCare’s Glucose Monitoring Device to the Cellnovo Gen 3 System

Cellnovo , a medical technology company marketing the first connected diabetes management platform based on a locked-down AndroidTM smartphone communicating via Bluetooth with a small , discreet micro-pump , today announces an agreement with ForaCare to enable the automatic transfer of data from ForaCare 's FORA Diamond Mini ® blood glucose monitoring device to the Cellnovo .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.